Biocryst Pharmaceuticals (BCRX) Change in Receivables: 2010-2015
Historic Change in Receivables for Biocryst Pharmaceuticals (BCRX) over the last 5 years, with Dec 2015 value amounting to -$1.3 million.
- Biocryst Pharmaceuticals' Change in Receivables fell 120.03% to -$1.3 million in Q4 2015 from the same period last year, while for Dec 2015 it was -$3.2 million, marking a year-over-year decrease of 144.03%. This contributed to the annual value of $22.7 million for FY2024, which is 272.40% up from last year.
- Per Biocryst Pharmaceuticals' latest filing, its Change in Receivables stood at -$1.3 million for Q4 2015, which was down 139.14% from $3.2 million recorded in Q3 2015.
- In the past 5 years, Biocryst Pharmaceuticals' Change in Receivables registered a high of $6.3 million during Q4 2014, and its lowest value of -$10.1 million during Q2 2011.
- Over the past 3 years, Biocryst Pharmaceuticals' median Change in Receivables value was -$245,500 (recorded in 2013), while the average stood at $140,083.
- As far as peak fluctuations go, Biocryst Pharmaceuticals' Change in Receivables slumped by 1,177.27% in 2013, and later skyrocketed by 2,561.42% in 2014.
- Over the past 5 years, Biocryst Pharmaceuticals' Change in Receivables (Quarterly) stood at -$5.8 million in 2011, then surged by 113.68% to $794,000 in 2012, then tumbled by 131.99% to -$254,000 in 2013, then skyrocketed by 2,561.42% to $6.3 million in 2014, then tumbled by 120.03% to -$1.3 million in 2015.
- Its Change in Receivables was -$1.3 million in Q4 2015, compared to $3.2 million in Q3 2015 and -$1.3 million in Q2 2015.